date:Apr 28, 2019
he second half of last year. Our measures have proven successful resulting in improved margins compared to H2 2018, says Tjerk de Ruiter, CEO.
It is also encouraging to see that Bakery returned to growth in Q1. The anticipated decline in Biochemicals was mostly due to phasing and we expect the Biochemicals sales growth rate to recover in the quarters to come. This was the first full operating quarter of our PLA joint venture plant and we are optimistic on the progress there, he adds.
Hersheys